DeleeBlood testing device for early diagnosis of cancer and treatment…

CytoCatch™ - Revolutionizing CTC Isolation and Analysis

Introduction

CytoCatch™ technology is designed to capture and analyze circulating tumor cells (CTCs) with unparalleled efficiency and reproducibility. This fully automated platform ensures high performance in isolating and analyzing CTCs, making it an essential tool for cancer research.

Key Features

• High Recovery Rates: Achieves over 97% recovery rates using multiple cancer cell lines from prostate, breast, lung, and colorectal cancer.
• Fully Automated: Eliminates human errors and cell loss due to manual steps, enhancing reliability and reproducibility.
• Advanced Imaging System: Utilizes computer vision and machine learning algorithms for accurate classification and enumeration of CTCs.
• Customizable Components: Offers flexibility with customizable objectives, fluorescent filter cubes, and LEDs.
• Molecular Analysis Compatibility: Captured cells are compatible with traditional molecular biology techniques and next-generation sequencing technologies.

Use Cases

• Cancer Research: Ideal for isolating and analyzing CTCs from various cancer types, aiding in the study of cancer progression and metastasis.
• Clinical Diagnostics: Enhances the accuracy of CTC enumeration and classification, providing valuable insights for clinical diagnostics.
• Personalized Medicine: Facilitates the development of personalized treatment plans by enabling detailed molecular analyses of captured CTCs.
• Pharmaceutical Development: Supports drug discovery and development by providing a reliable platform for testing the efficacy of new cancer treatments.

Pricing

CytoCatch™ offers competitive pricing tailored to meet the needs of different research and clinical settings. Contact us for detailed pricing information and to find the best solution for your requirements.

Teams

Our dedicated team at Delee Corp. is committed to advancing cancer research through innovative technology. We work closely with researchers, clinicians, and pharmaceutical companies to provide cutting-edge solutions for CTC isolation and analysis. Join us in pushing the boundaries of cancer research and making a difference in the fight against cancer.